Global leader in cancer clinical trials
The science of collaboration begins with us
We partner with pharmaceutical and biotech companies, physicians and patients to advance the science of cancer treatments.
Sarah Cannon Research Institute (SCRI) is a global leader in oncology research, conducting clinical trials in the community for more than 30 years. Our contributions to pivotal research have helped to advance the majority of new cancer therapies approved by the FDA today.
250+
locations in 24 states
1 in 5
patients with cancer reached through our affiliated sites
1,300+
research physicians
